Style | Citing Format |
---|---|
MLA | Khalighfard S, et al.. "Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144] (European Journal of Pharmacology (1998) 342(1) (67–76), (S0014299997014179), (10.1016/S0014-2999(97)01417-9))." European Journal of Pharmacology, vol. 980, no. , 2024, pp. -. |
APA | Khalighfard S, Kalhori MR, Haddad P, Khori V, Mohammadalizadeh A (2024). Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144] (European Journal of Pharmacology (1998) 342(1) (67–76), (S0014299997014179), (10.1016/S0014-2999(97)01417-9)). European Journal of Pharmacology, 980(), -. |
Chicago | Khalighfard S, Kalhori MR, Haddad P, Khori V, Mohammadalizadeh A. "Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144] (European Journal of Pharmacology (1998) 342(1) (67–76), (S0014299997014179), (10.1016/S0014-2999(97)01417-9))." European Journal of Pharmacology 980, no. (2024): -. |
Harvard | Khalighfard S et al. (2024) 'Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144] (European Journal of Pharmacology (1998) 342(1) (67–76), (S0014299997014179), (10.1016/S0014-2999(97)01417-9))', European Journal of Pharmacology, 980(), pp. -. |
Vancouver | Khalighfard S, Kalhori MR, Haddad P, Khori V, Mohammadalizadeh A. Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144] (European Journal of Pharmacology (1998) 342(1) (67–76), (S0014299997014179), (10.1016/S0014-2999(97)01417-9)). European Journal of Pharmacology. 2024;980():-. |
BibTex | @article{ author = {Khalighfard S and Kalhori MR and Haddad P and Khori V and Mohammadalizadeh A}, title = {Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144] (European Journal of Pharmacology (1998) 342(1) (67–76), (S0014299997014179), (10.1016/S0014-2999(97)01417-9))}, journal = {European Journal of Pharmacology}, volume = {980}, number = {}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Khalighfard S AU - Kalhori MR AU - Haddad P AU - Khori V AU - Mohammadalizadeh A TI - Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144] (European Journal of Pharmacology (1998) 342(1) (67–76), (S0014299997014179), (10.1016/S0014-2999(97)01417-9)) JO - European Journal of Pharmacology VL - 980 IS - SP - EP - PY - 2024 ER - |